| Success/Failure Stories and Lessons Learned from conducting R&D in China | | | | | |
|---|
| Major Pharma's Approach to Innovation in China | | | | | |
|---|
| Next Generation Biologics/Biosimilars/Biobetters | | | | | |
|---|
| Generic Drug Development | | | | | |
|---|
| Vaccine Development | | | | | |
|---|
| Therapeutics Update - Cancer, Diabetes/Obesity, Tropical Diseases, Influenza etc. | | | | | |
|---|
| Translational Research | | | | | |
|---|
| Regenerative Medicine/Stem Cells/Cell & Gene Therapy | | | | | |
|---|
| Early Discovery | | | | | |
|---|
| PreClinical Development | | | | | |
|---|
| Clinical Trials in China for Global Pharma | | | | | |
|---|
| Clinical Trials in US/EU for Chinese Pharma | | | | | |
|---|
| Manufacturing | | | | | |
|---|
| Commercialization | | | | | |
|---|
| Creating Value Through Partnerships | | | | | |
|---|